The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117924022 11792402 2 F 20091213 20160823 20151202 20160913 EXP US-ROCHE-1670453 ROCHE 57.00 YR F Y 66.20000 KG 20160914 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117924022 11792402 1 PS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) OVER 30 TO 90 MINUTES ON DAYS 1 AND 15 (1324 MG) 125085 10 MG/KG SOLUTION FOR INFUSION
117924022 11792402 2 SS Bevacizumab BEVACIZUMAB 1 125085
117924022 11792402 3 SS Bevacizumab BEVACIZUMAB 1 125085
117924022 11792402 4 SS TEMSIROLIMUS TEMSIROLIMUS 1 Intravenous (not otherwise specified) ON DAYS 1,8,15,22 0 75 MG
117924022 11792402 5 SS TEMSIROLIMUS TEMSIROLIMUS 1 0
117924022 11792402 6 SS TEMSIROLIMUS TEMSIROLIMUS 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117924022 11792402 1 Ovarian cancer
117924022 11792402 2 Hepatocellular carcinoma
117924022 11792402 3 Malignant neoplasm of islets of Langerhans
117924022 11792402 4 Ovarian cancer
117924022 11792402 5 Hepatocellular carcinoma
117924022 11792402 6 Hepatocellular carcinoma

Outcome of event

Event ID CASEID OUTC COD
117924022 11792402 DE
117924022 11792402 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
117924022 11792402 Death
117924022 11792402 Stevens-Johnson syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
117924022 11792402 1 20091125 20091209 0
117924022 11792402 4 20091125 20091209 0